enteropathogen
coronaviru
transmiss
gastroenter
viru
tgev
caus
sever
diseas
young
piglet
studi
protect
effect
probiot
enterococcu
faecium
ncimb
e
faecium
approv
feed
addit
european
union
tgev
infect
e
faecium
ad
swine
testicl
st
cell
concomitantli
tgev
infect
viabil
assay
reveal
e
faecium
led
dosedepend
rescu
viabil
tgevinfect
cell
reach
nearli
complet
protect
viru
yield
e
faeciumtr
cultur
reduc
three
log
unit
western
blot
analysi
purifi
tgev
reveal
level
viral
structur
protein
reduc
e
faecium
treatment
use
transmiss
electron
microscopi
observ
attach
tgev
particl
surfac
e
faecium
might
mean
trap
viru
prevent
infect
increas
product
nitric
oxid
cell
treat
e
faecium
elev
express
interleukin
point
stimul
cellular
defens
mechan
fight
tgev
infect
transmiss
gastroenter
viru
tgev
infect
enter
respiratori
tissu
caus
sever
gastroenter
mortal
rate
close
newborn
piglet
appear
close
relat
tgev
variant
porcin
respiratori
coronaviru
prcov
found
benefici
prevent
tgev
infect
possibl
induct
neutral
antibodi
provid
crossprotect
tgev
infect
howev
tge
preval
still
report
tgev
strain
isol
domest
pig
differ
part
world
commerci
avail
vaccin
either
inactiv
attenu
fail
provid
full
protect
piglet
like
parent
appli
inactiv
virus
induc
local
immun
respons
small
intestin
requir
protect
therefor
discoveri
develop
new
highli
potent
antitgev
agent
effect
approach
control
emerg
tgev
infect
remain
import
mission
probiot
defin
live
microbi
food
supplement
healthpromot
attribut
potent
mechan
benefici
action
includ
product
antimicrobi
agent
modul
immun
respons
promot
host
innat
defens
mechan
enterococcu
faecium
ncimb
e
faecium
author
eu
use
probiot
feed
addit
sow
piglet
sever
farm
anim
speci
benefici
effect
probiot
e
faecium
immun
modul
improv
nutrient
transport
previous
report
sever
studi
vitro
studi
also
demonstr
e
faecium
could
reduc
rate
invas
pathogensfor
instanc
salmonella
intestin
cell
line
detail
knowledg
impact
e
faecium
viral
infect
vivo
vitro
lack
purpos
present
studi
establish
vitro
model
investig
antivir
potenti
e
faecium
use
establish
swine
testicl
st
cell
line
assess
protect
effect
e
faecium
tgev
infect
term
viral
replic
cell
surviv
gain
insight
possibl
mechan
action
effect
e
faecium
viral
protein
synthesi
well
induct
induc
nitric
oxid
synthas
ino
select
cytokin
investig
result
describ
suggest
probiot
e
faecium
strain
exhibit
antivir
activ
tgev
may
possibl
serv
use
antivir
agent
coronaviru
infect
vivo
epitheli
swine
testicl
st
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
pan
biotech
supplement
fetal
bovin
serum
hyclon
penicillinstreptomycin
biochrom
grow
co
humidifi
incub
tgev
strain
purdu
kindli
provid
dr
c
schwegmannwessel
institut
virologi
hochschul
hannov
use
studi
stock
viru
propag
st
cell
titer
pfuml
infect
done
multipl
infect
enterococcu
faecium
ncimb
isol
commerci
product
use
anim
nutrit
cylactin
cerbiospharma
sa
lugano
use
studi
cultiv
toddhewittbouillon
thb
roth
number
viabl
bacteria
ml
bacteri
cultur
determin
plate
bacteria
agar
bacteri
cultur
centrifug
rpm
min
bacteria
wash
twice
remov
excess
thb
final
viabl
e
faecium
particl
resuspend
dmem
stock
concentr
cfuml
heat
inactiv
bacteria
perform
heat
treatment
e
faecium
cfuml
dmem
water
bath
min
bacteri
cultur
supernat
obtain
grow
bacteri
cultur
thb
bacteria
remov
centrifug
rpm
min
supernat
collect
assess
cellular
toxic
e
faecium
suspens
contain
differ
amount
e
faecium
rang
ad
st
cell
monolay
plate
greiner
bioon
h
wash
away
end
incub
period
methylthiazolyldiphenyltetrazolium
bromid
mtt
viabil
assay
carri
describ
previous
cell
surviv
rate
determin
bacteria
averag
od
valuecontrol
averag
od
valu
cytotox
concentr
cc
defin
concentr
inhibit
cell
prolifer
noncytotox
concentr
e
faecium
use
antivir
assay
four
differ
experiment
protocol
appli
investig
antivir
activ
e
faecium
three
setup
focus
effect
e
faecium
cell
vari
treatment
period
relat
infect
tgev
fourth
setup
assess
direct
effect
probiot
viru
particl
brief
monolay
st
cell
treat
e
faecium
h
wash
away
infect
tgev
h
pretreat
assay
e
faecium
tgev
ad
cell
layer
togeth
infect
period
competit
assay
e
faecium
ad
h
right
infect
period
postinfect
treatment
assay
probiot
treatment
well
infect
tgev
cell
wash
twice
kept
medium
contain
penicillinstreptomycin
kill
viabl
bacteria
left
assess
direct
effect
e
faecium
tgev
without
cell
involv
viru
mix
differ
concentr
e
faecium
incub
h
centrifug
min
rpm
sediment
bacteri
cell
viru
contain
supernat
use
infect
st
cell
cellfre
preincub
assay
antivir
effect
heatinactiv
e
faecium
well
serial
dilut
e
faecium
supernat
also
test
competit
assay
virusinfect
st
cell
cell
without
addit
e
faecium
serv
control
sampl
collect
h
infect
hpi
tissu
cultur
infect
dose
tcid
mtt
viabil
assay
respect
rel
surviv
cell
calcul
follow
percent
viabl
cell
od
valu
e
faecium
group
od
valu
infect
control
od
valu
blank
control
od
valu
infect
control
transmiss
electron
microscopi
tem
order
examin
possibl
direct
bind
viru
e
faecium
cellfre
preincub
assay
perform
mix
e
faecium
tgev
bacteriatoviru
ratio
h
centrifug
min
rpm
sediment
bacteri
cell
pellet
resuspend
ml
karnovski
fix
sampl
centrifug
min
rpm
drop
taken
bottom
tube
neg
stain
phosphotungst
acid
min
final
sampl
evalu
transmiss
electron
microscop
zeiss
viru
yield
reduct
assay
st
cell
monolay
infect
tgev
without
probiot
bacteria
treatment
accord
experiment
design
hpi
aliquot
supernat
taken
serial
tenfold
dilut
step
perform
infect
determin
endpoint
dilut
titrat
st
cell
plate
plate
incub
hpi
infect
determin
record
virusinduc
cytopath
effect
cpe
viru
titer
calcul
method
reed
muench
usual
use
calcul
ld
document
tcid
valu
st
cell
infect
cultur
dish
growth
area
competit
assay
condit
e
faecium
hpi
viru
cell
cultur
fluid
cell
collect
ultracentrifug
ultracentrifug
beckman
coulter
rpm
h
use
rotor
pellet
contain
viru
particl
equal
amount
total
protein
underw
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
separ
protein
electrotransf
hybond
lfp
pvdf
membran
ge
healthcar
use
felin
antitg
polyclon
antiserum
natutec
dilut
antifelin
igg
polyclon
antiserum
rockland
dilut
antigenantibodi
complex
detect
use
western
blot
substrat
pierc
ecl
plu
immunodetect
protein
band
membran
visual
use
fusion
imag
system
vilber
lourmat
protein
amount
estim
densitometr
analysi
use
fusioncapt
softwar
vilber
lourmat
three
independ
experi
appropri
gel
exposur
yield
similar
result
treatment
modal
detect
nitric
oxid
releas
hpi
differ
assay
releas
determin
measur
amount
releas
use
griessassay
promega
accord
manufactur
protocol
lp
mgml
stimul
cell
use
posit
control
sampl
untreat
cell
without
prior
infect
serv
defin
basal
valu
total
rna
st
cell
isol
use
gene
matrix
rna
purif
kit
eurx
describ
manufactur
revers
transcript
rt
perform
use
revertaidtm
first
strand
cdna
synthesi
kit
fermenta
accord
manufactur
instruct
pcr
reaction
perform
total
volum
icycl
detect
system
biorad
laboratori
data
analysi
base
measur
cycl
threshold
c
differ
ct
valu
untreat
sampl
versu
treat
sampl
calcul
use
deltadeltact
method
sampl
measur
triplic
three
independ
experi
name
gene
genbank
access
number
primer
sequenc
anneal
temperatur
size
amplif
product
list
tabl
calcul
perform
ibm
spss
statist
analysi
viru
titer
detect
perform
two
one
factori
anova
respect
follow
post
hoc
test
cytokin
express
data
analysi
perform
pair
ttest
pvalu
less
consid
statist
signific
data
given
mean
sd
probiot
e
faecium
use
interfer
studi
concentr
rang
addit
cell
nontox
defin
result
cell
viabil
assay
fig
show
e
faecium
nontox
concentr
cfuml
viabil
rate
st
cell
morpholog
differ
observ
bacteriatr
mocktreat
cell
concentr
therefor
highest
concentr
e
faecium
chosen
interfer
studi
tgev
cfuml
cc
e
faecium
st
cell
calcul
cfuml
fig
show
e
faecium
provid
protect
tgev
infect
dosedepend
manner
protect
achiev
highest
concentr
e
faecium
cfuml
probiot
ad
cell
togeth
viru
infect
period
competit
assay
find
whether
e
faecium
inactiv
tgev
particl
direct
physic
interact
viru
cellfre
preincub
assay
perform
result
show
infect
tgev
also
reduc
concentrationdepend
manner
result
mtt
assay
fig
confirm
flow
cytometri
use
propidium
iodid
stain
independ
experi
data
shown
furthermor
illustr
electron
microscopi
fig
viru
particl
seem
bound
e
faecium
attach
e
faecium
surfac
competit
assay
exhibit
pronounc
antivir
activ
term
cell
surviv
fig
antivir
effect
heatkil
e
faecium
e
faecium
supernat
competit
assay
also
test
result
fig
c
show
heatkil
e
faecium
e
faecium
supernat
still
antivir
activ
much
less
pronounc
suggest
live
e
faecium
necessari
exhibit
observ
virusreduc
effect
antitgev
activ
e
faecium
confirm
measur
releas
infecti
viru
cultur
medium
use
tcid
assay
expect
result
fig
consist
cell
viabil
assay
sinc
tgev
yield
found
reduc
treatment
e
faecium
inhibit
viru
product
effect
competit
assay
cell
expos
highest
concentr
e
faecium
cfuml
amount
threelog
reduct
reduc
viru
titer
also
found
cellfre
preincub
assay
indic
probiot
e
faecium
also
antivir
capac
level
direct
physic
interact
viru
particl
tgev
produc
larg
scale
e
faecium
interfer
condit
competit
assay
enrich
ultracentrifug
subject
sdspage
follow
western
blot
analysi
protein
assay
reveal
strongli
reduc
amount
total
viral
protein
viru
probiot
treat
cell
analyz
fig
dilut
efaecium
metabol
product
h
mtt
assay
carri
result
plot
percent
viabil
uninfect
cell
without
e
faecium
taken
result
given
mean
standard
deviat
least
three
independ
experi
probiot
infect
period
tgev
protein
level
reduc
importantli
western
blot
antibodi
rais
total
tgev
protein
densitometr
inspect
fail
show
major
aberr
rel
polypeptid
composit
viru
particl
indic
level
viral
protein
evenli
reduc
first
approach
elucid
mechan
effect
probiot
treatment
tgev
product
synthesi
antivir
measur
shown
tabl
level
posit
control
lp
strong
induc
releas
cytokin
import
compon
cellular
defens
mechan
microbi
infect
treatment
st
cell
probiot
could
modul
cellular
express
pattern
cytokin
therebi
reduc
effici
tgev
multipl
first
step
test
hypothesi
studi
product
select
cytokin
influenc
e
faecium
tgevand
mockinfect
st
cell
h
h
h
h
hpi
competit
assay
clear
increas
express
cytokin
observ
reach
highest
level
express
hpi
result
show
administr
cfuml
e
faecium
togeth
viru
significantli
increas
mrna
express
level
proinflammatori
cytokin
interleukin
approxim
increas
respect
compar
tgevinfect
st
cell
expos
probiot
fig
tumor
necrosi
factoralpha
tnfa
interferon
ifna
tolllik
mrna
express
show
less
pronounc
increas
compar
tgevinfect
cell
expos
probiot
administr
cfuml
e
faecium
alon
increas
similar
mrna
express
level
cytokin
level
appar
detect
limit
pcr
assay
appli
studi
assess
potenti
prophylact
therapeut
effect
probiot
bacteria
e
faecium
tgev
infect
increas
concentr
probiot
e
faecium
bacteria
ad
st
cell
concomitantli
tgev
infect
short
period
time
cell
viabil
well
viru
titer
cultur
medium
quantit
assess
later
longterm
incub
low
moi
chosen
order
allow
multipl
infect
cycl
close
reflect
natur
infect
pretreat
st
cell
e
faecium
pretreat
viabil
tgevinfect
cell
protect
viru
yield
reduc
fig
appear
e
faecium
interfer
viru
attach
andor
entri
cell
sever
studi
demonstr
probiot
block
viral
attach
competit
inhibit
abl
bind
viral
receptor
surfac
cell
freita
cowork
report
lactobacillu
casei
strain
strain
bacteroid
thetaiotaomicron
produc
solubl
compound
partial
protect
epitheli
cell
rotaviru
infect
vitro
modul
apic
glycosyl
pattern
cell
postinfect
treatment
assay
suggest
antivir
activ
e
faecium
also
contribut
stimul
proinflammatori
factor
ie
increas
mrna
express
level
pagnini
cowork
shown
multipl
probiot
formul
vsl
could
stimul
epitheli
product
tnfa
activ
nfjb
vitro
probiot
bacteria
may
also
indirectli
interfer
viru
alter
state
cell
stimul
innat
andor
adapt
immun
studi
express
antivir
cytokin
may
alter
state
cell
eventu
lead
antivir
respons
cellfre
preincub
assay
improv
surviv
signific
drop
viru
titer
also
observ
fig
theori
viru
could
also
fail
infect
host
cell
trap
adsorpt
bacteri
surfac
tem
result
fig
observ
viru
particl
trap
e
faecium
may
molecular
mimicri
bacteri
surfac
molecul
glycoprotein
sialic
acid
eukaryot
cellular
receptor
use
viru
attach
studi
competit
assay
viru
probiot
bacteria
present
cultur
medium
side
side
exhibit
pronounc
antivir
activ
term
cell
surviv
fig
pronounc
antivir
activ
like
result
sum
overlap
mechan
differ
time
point
viru
infect
shown
includ
find
level
viral
structur
protein
equival
reduc
e
faecium
treatment
fig
indic
inde
fewer
tgev
particl
releas
infect
cell
likewis
reduc
synthesi
tgev
protein
may
decreas
amount
virusinduc
damag
subsequ
also
amelior
cytopath
effect
virusinfect
st
cell
logic
must
lead
rescu
cell
viabil
competit
assay
effect
antivir
approach
look
possibl
direct
mechan
effect
probiot
treatment
look
releas
infect
cell
found
e
faecium
could
significantli
induc
releas
tabl
antivir
effect
well
studi
sever
viral
infect
although
product
believ
releas
mainli
macrophag
detect
increas
releas
st
cell
upon
treatment
e
faecium
tgev
releas
dose
depend
indic
induct
ino
could
inde
play
role
mechan
observ
e
faecium
inhibit
tgev
infect
st
cell
competit
assay
also
compar
express
antivir
cytokin
tgev
infect
st
cell
without
e
faecium
significantli
increas
express
compar
mock
control
howev
e
faecium
treatment
significantli
increas
product
proinflammatori
factor
tgevinfect
st
cell
result
consist
author
show
product
follow
interact
probiot
intestin
epithelium
respons
intestin
epitheli
cell
play
import
role
pathogenesi
immun
defens
enter
pathogen
increas
level
cytokin
could
also
possibl
indic
enhanc
innat
respons
accord
scientif
opinion
probiot
concentr
cfug
intestin
content
requir
elicit
potenti
benefit
host
feed
trial
piglet
concentr
cfu
e
faeciumg
digesta
could
detect
intestin
thu
although
directli
compar
effect
concentr
e
faecium
use
present
studi
similar
rang
add
relev
data
conclus
result
present
studi
show
e
faecium
inhibit
tgev
replic
st
cell
possibl
overlap
mechan
lead
observ
reduct
viru
growth
direct
interfer
viru
attach
adsorpt
trap
inactiv
viru
particl
surfac
compon
probiot
bacteria
stimul
proinflammatori
cytokin
well
product
data
suggest
e
faecium
may
serv
use
antivir
agent
infect
tgev
possibl
virus
challeng
experi
differ
porcin
virus
piglet
way
substanti
hypothesi
